1,4,6-androstatrien-3,17-dione: Difference between revisions
Jump to navigation
Jump to search
m (Protected "1,4,6-androstatrien-3,17-dione": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 8: | Line 8: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{chemistry-stub}} | {{chemistry-stub}} | ||
Latest revision as of 13:46, 4 September 2012
This article needs attention from an expert in Pharmacology. |
1,4,6-androstatrien-3,17-dione (ATD) is a potent irreversible aromatase inhibitor that inhibits estrogen biosynthesis by permanently binding and inactivating aromatase in adipose and peripheral tissue. [1]
A related agent is exemestane (Aromasin).
References
- ↑ Covey DF, Hood WF. (1981). "Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity". Endocrinology 108 (4): 1597-9. PMID 7472286.
Categories:
- Pages with broken file links
- Articles needing expert attention with no reason or talk parameter
- Articles needing expert attention
- All articles needing expert attention
- Miscellaneous articles needing expert attention
- Orphaned articles from September 2007
- Articles with invalid date parameter in template
- All orphaned articles
- Aromatase inhibitors